focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further regulatory approval recommendations

8 Jul 2011 07:00

RNS Number : 0150K
PureCircle Limited
08 July 2011
 



PURECIRCLE LIMITED

("PureCircle" or the "Company")

FURTHER REGULATORY APPROVAL RECOMMENDATIONS FOR STEVIA

PureCircle (LSE: PURE), the world's largest producer and marketer of high purity stevia, today provides a stevia market update concerning the Codex Alimentarius Commission adoption of proposed maximum levels for steviol glycosides.

PureCircle notes that during its meeting this week, the Codex Alimentarius Commission (CAC), adopted all the proposed draft maximum levels for steviol glycosides as submitted for adoption by the Codex Committee on Food Additives (CCFA). The CAC official report will be issued after the end of the meeting on July 9th.

The Codex Alimentarius Commission, or Codex, was created by the Food and Agriculture Organization (FAO) and the World Health Organization (WHO). Its main purposes are to protect the health of consumers and to ensure fair practices in international trade in food through the development of food standards, codes of practice, guidelines and other recommendations. Codex standards and guidelines are developed by committees, which are open to all UN member countries. The Codex standards and guidelines are then used by many countries as the benchmark for their own internal approval processes.

As part of the adoption, the approved maximum use levels across all major food and beverage categories have now been defined. This is the last outstanding major approval that will unlock a number of important markets such as India, Indonesia, Thailand, and Philippines. Such countries look for the Codex adoption of a food ingredient to support their evaluation and approval. PureCircle has been actively engaged in these markets on regulatory approval and market development.

Commenting on the adoption by the Codex Alimentarius Commission, PureCircle CEO Magomet Malsagov said "This has been an important week for approval and adoption of stevia as a mainstream food ingredient around the globe. Early this week, we had a positive vote by the EU Standing Committee recommending steviol glycosides in Europe. We now welcome this week's Codex adoption which will help to open all remaining new markets for PureCircle's high purity stevia products around the world."

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO

+44 7974 005 163

RFC Corporate Finance (NOMAD)

+61 8 9480 2500

Steve Allen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REAUBUNRAKABRAR
Date   Source Headline
29th Oct 20097:00 amRNSProduct Launch
27th Oct 200912:35 pmRNSHolding(s) in Company
21st Oct 20097:00 amRNSPureCircle and PepsiCo to receive Scientific Excel
20th Oct 20097:00 amRNSProduct Launch
15th Oct 200910:00 amRNSTrading Statement
8th Oct 20097:00 amRNSDirector Declaration
23rd Sep 20097:00 amRNSFinal Results
8th Sep 20098:32 amRNSStatement re Approval
4th Sep 20093:00 pmRNSStatement re Shareholding
2nd Sep 200910:10 amRNSChange of Adviser
8th Jul 20097:00 amRNSTrading Update
15th Jun 20098:41 amRNSNotification of a Major Interest
27th Apr 20097:02 amRNSCompletion of Extract Plant Complex
1st Apr 20097:00 amRNSDealings in Shares
5th Mar 20099:20 amRNSDirector's Dealing
4th Mar 20097:00 amRNSHalf Yearly Report
29th Jan 20097:00 amRNSSENIOR INTERNATIONAL SALES TEAM APPOINTMENT
19th Jan 20097:00 amRNSAppointment
13th Jan 20097:00 amRNSAppointment of Head of PureCircle USA
12th Jan 20097:09 amRNSNotice of Results
6th Jan 20097:00 amRNSStrategic Global Collaboration
5th Jan 20097:00 amRNSDirector Dealings
18th Dec 20087:00 amRNSRegulatory Approval
24th Nov 20087:51 amRNSExecutive Management Appointments
10th Nov 20087:55 amRNSIssuance of Options
7th Nov 20089:51 amRNSExercise of Options
17th Oct 20083:05 pmRNSDealings in shares
15th Oct 20087:00 amRNSFinal Results
13th Oct 200812:58 pmRNSBoard Change
10th Oct 20089:44 amRNSApproval Announced
22nd Aug 20087:00 amRNSRevised Results Day
20th Aug 20088:42 amRNSBoard Appointment
31st Jul 20083:42 pmRNSMajor contract win
21st Jul 20088:45 amRNSNotice of Interim Results
2nd Jul 20088:10 amRNSRe Share Holdings
2nd Jul 20087:03 amRNSDirector's Dealings
1st Jul 20081:08 pmRNSStrategic Partnership
16th Jun 20088:34 amRNSLong Term Incentive Plan
2nd Jun 20089:27 amRNSAGM and Board appointments
2nd Jun 20087:00 amRNSDealings in Shares
20th May 20089:08 amRNSCompletion of aquisition and
9th May 20088:39 amRNSNotice of AGM
7th May 20087:00 amRNSAppointment
6th May 20088:33 amRNSKenya Joint Venture
22nd Apr 200811:19 amRNSInvestor Presentation
7th Apr 20088:37 amRNSAcquisition
1st Apr 20087:01 amRNSFinal Results
31st Mar 20089:19 amRNSNotification re: results
10th Mar 20081:16 pmRNSResults Date
28th Feb 20088:43 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.